Profiling of peritoneal ultrafiltration

Slides:



Advertisements
Similar presentations
2002 Air Medical Transport Industry Awards Air Medical Journal Volume 22, Issue 2, Pages (March 2003) DOI: /S X(03) Copyright.
Advertisements

Urea and nitrogen excretion in pediatric peritoneal dialysis patients
Acid-base profile in patients on PD
Volume 59, Issue 2, Pages (February 2001)
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Buffer transport in peritoneal dialysis
Volume 70, Pages S138-S145 (November 2006)
Volume 70, Issue 8, Pages (October 2006)
Anemia management in chronic kidney disease
Acid-base profile in patients on PD
Use of icodextrin in high transport ultrafiltration failure
Impact of new dialysis solutions on peritonitis rates
Volume 72, Issue 8, Pages (October 2007)
Volume 64, Pages S3-S12 (December 2003)
Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy  G. Viglino, L. Neri, S. Barbieri  Kidney.
Volume 53, Issue 4, Pages (April 1998)
Volume 69, Issue 5, Pages (March 2006)
Progression of renal failure and hypertensive nephrosclerosis
Glucose sparing in peritoneal dialysis: Implications and metrics
Ali K. Abu-Alfa, John Burkart, Beth Piraino, Joe Pulliam, Salim Mujais 
Volume 57, Issue 6, Pages (June 2000)
Clinical Snippets Journal of Investigative Dermatology
Volume 55, Issue 6, Pages (June 1999)
George A. Kaysen, Burl R. Don
V. La Milia, M. Limardo, G. Virga, M. Crepaldi, F. Locatelli 
D. Batlle, P. Ramadugu, M.J. Soler  Kidney International 
Severe exfoliative skin rash with icodextrin
Volume 55, Issue 2, Pages (February 1999)
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Edmund G. Lowrie  Kidney International 
Health-related quality of life predicts outcomes but is not affected by peritoneal clearance: The ADEMEX trial  Ramon Paniagua, Dante Amato, Edward Vonesh,
Volume 73, Pages S5-S17 (April 2008)
Pharmacokinetics of icodextrin in peritoneal dialysis patients
Body size and outcomes on peritoneal dialysis in the United States
Volume 73, Pages S94-S101 (April 2008)
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure  A. Parikova, W. Smit, D.G. Struijk,
Clinical Snippets Journal of Investigative Dermatology
Clifford J. Holmes, Dirk Faict  Kidney International 
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Microbiology and outcomes of peritonitis in North America
Nephrology in Latin America, with special emphasis on Brazil
Nephrology Crossword: Peritoneal Dialysis
Future of icodextrin as an osmotic agent in peritoneal dialysis
AGEs in foods: Do they play a role in uremia?
Volume 73, Pages S72-S75 (April 2008)
Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes  Sr. Anne B. Bakewell, Rob M. Higgins, Mair.
Homocysteine, renal function, and risk of cardiovascular disease
Urea and nitrogen excretion in pediatric peritoneal dialysis patients
Peritoneal dialysis in Mexico
Volume 70, Pages S84-S90 (November 2006)
Volume 53, Issue 5, Pages (May 1998)
Biocompatibility of icodextrin
Volume 56, Pages S37-S40 (November 1999)
Charles A. Herzog  Kidney International 
Quantification of free water transport in peritoneal dialysis
ANCA comes of age—but with caveats
Review of clinical trial experience with icodextrin
Volume 70, Issue 5, Pages (September 2006)
Volume 59, Issue 2, Pages (February 2001)
Volume 65, Issue 1, Pages (January 2004)
Strategies for iron supplementation: Oral versus intravenous
The International Pediatric Peritonitis Registry: Starting to walk
Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis  Karl-Georg Fischer, M.D., Andreas van.
Clinical Practice Recommendations For Peritoneal Dialysis Adequacy
E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins 
Morphology of the heart and arteries in renal failure
Clinical Practice Guidelines for Peritoneal Dialysis Adequacy
Metabolic and laboratory effects of icodextrin
Presentation transcript:

Profiling of peritoneal ultrafiltration Salim Mujais, Edward Vonesh  Kidney International  Volume 62, Pages S17-S22 (October 2002) DOI: 10.1046/j.1523-1755.62.s81.4.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Time profiles of opposing forces governing ultrafiltration (transcapillary ultrafiltration and lymphatic absorption). Symbols are: (•) absorption; (□) transcapillary UF; (▴) net UF. The net effect of these two processes is represented as net UF. Redrawn from Mactier et al17; used with permission of the Journal of Clinical Investigation. Kidney International 2002 62, S17-S22DOI: (10.1046/j.1523-1755.62.s81.4.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Proportional distribution of patients in the standard transport categories by PET. Data are from 1229 patients. Kidney International 2002 62, S17-S22DOI: (10.1046/j.1523-1755.62.s81.4.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Ultrafiltration during the PET displayed by transport category with mean and SD showing a very high degree of overlap between the four categories. Abbreviations are: L, low transport; LA, low average transport; HA, high average transport; H, high transport group. Kidney International 2002 62, S17-S22DOI: (10.1046/j.1523-1755.62.s81.4.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 4 Temporal profile of net ultrafiltration in the four standard transport categories with the use of 1.5% dextrose solution. Symbols are: (•) low transport; (□) low average transport; (▴) high average transport; (▪) high transport group. Kidney International 2002 62, S17-S22DOI: (10.1046/j.1523-1755.62.s81.4.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 5 Temporal profile of net ultrafiltration in the four standard transport categories with the use of 2.5% dextrose solution. Symbols are: (•) low transport; (□) low average transport; (▴) high average transport; (▪) high transport group. Kidney International 2002 62, S17-S22DOI: (10.1046/j.1523-1755.62.s81.4.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 6 Temporal profile of net ultrafiltration in the four standard transport categories with the use of 4.25% dextrose solution. Symbols are: (•) low transport; (□) low average transport; (▴) high average transport; (▪) high transport group. Kidney International 2002 62, S17-S22DOI: (10.1046/j.1523-1755.62.s81.4.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 7 Temporal profile of net ultrafiltration in the four standard transport categories with the use of 7.5% icodextrin solution. Symbols are: (•) low transport; (□) low average transport; (▴) high average transport; (▪) high transport group. Kidney International 2002 62, S17-S22DOI: (10.1046/j.1523-1755.62.s81.4.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 8 Temporal profile of net ultrafiltration in high average transport patients with the use of (•) 1.5%, (□) 2.5%, (▪) 4.25% dextrose or (▴) 7.5% icodextrin solutions. Kidney International 2002 62, S17-S22DOI: (10.1046/j.1523-1755.62.s81.4.x) Copyright © 2002 International Society of Nephrology Terms and Conditions